Currently used pain assessment tools may be underestimating the pain response in infants according to a study published in the open access journal PLoS Medicine this week. Dr Slater and colleagues (University College London, UK) studied the association between cortical pain responses in young infants and currently used pain assessment tools which are based on behavioural and physiological measures, such as change in facial expression.
Evidence suggests that inadequate pain management in infants may have immediate and long-term effects. Repetitive pain in preterm infants has been associated with attention deficit disorder, learning disorders and behavioural problems in later childhood.
The researchers studied twelve clinically stable infants on 33 occasions when they required a heel lance for a clinical reason. The relationship between brain activity and a clinical pain score, calculated using the premature infant pain profile (PIPP), was examined in response to this painful event. They found that changes in brain activity correlated to the PIPP scores. These changes were more strongly linked to the behavioural components of the PIPP, e.g., facial expression, than physiological components, e.g., heart rate. They also observed no change in facial expression in 13 of the 33 test occasions but 10 of these showed a positive brain response.
While this was a small single-centre study on clinically stable infants, the results raise further awareness of the ability of infants to experience pain. And, as the authors say, the results highlight the possibility that "pain assessment based on behavioural tools alone should be interpreted with caution as they could under estimate the total pain response."
Citation: Slater R, Cantarella A, Franck L, Meek J, Fitzgerald M (2008) How well do clinical pain assessment tools reflect pain in infants? PLoS Med 5(6): e129.
http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0050129
Source: Public Library of Science
Related stories:
Commonly used drug offers promise for premature babies
Scientists have found evidence that the cox-2 inhibitor celecoxib, a common pain reliever used to treat arthritis, may offer a new way to reduce the risk of the most common cause of brain damage in babies born prematurely.
Steroid treatment offers no benefit in preemies, study suggests
Results of a multicenter study led by Johns Hopkins Children's Center challenge the longstanding practice of treating premature babies with hydrocortisone, a steroid believed to fight inflammation and prevent lung disease. The researchers found that such treatment offers little or no benefit and that low cortisol levels are not even necessarily harmful. High cortisol levels, on the other hand, appeared to increase the risk of dangerous bleeding in the brain and require that babies be monitored aggressively to ward off life-threatening complications, according to the study published in the October issue of
Pediatrics.
Codeine not safe for all breastfeeding moms and their babies
Using pain treatments which contain codeine may be risky for some breastfeeding mothers, according to researchers at The University of Western Ontario, and the Hospital for Sick Children (SickKids) in Toronto. Lead author Dr. Gideon Koren published research in the journal, Clinical Pharmacology & Therapeutics which suggests that the codeine used in some pain relief drugs can actually have harmful and even fatal results for infants when ingested by some breastfeeding mothers.
Relaxation response can influence expression of stress-related genes
How could a single, nonpharmacological intervention help patients deal with disorders ranging from high blood pressure, to pain syndromes, to infertility, to rheumatoid arthritis? That question may have been answered by a study finding that eliciting the relaxation response – a physiologic state of deep rest – influences the activation patterns of genes associated with the body's response to stress. The collaborative investigation by members of the Benson-Henry Institute for Mind/Body Medicine at Massachusetts General Hospital (MGH) and the Genomics Center at Beth Israel Deaconess Medical Center (BIDMC) appears in the open-access journal
PLoS One.
Newborns in ICUs often undergo painful procedures, most without pain medication
An examination of newborn intensive care finds that newborns undergo numerous procedures that are associated with pain and stress, and that many of these procedures are performed without medication or therapy to relieve pain, according to a study in the July 2 issue of
JAMA.
Ethical implications of modifying lethal injection protocols
A team of medical, ethical, and legal scholars argues in this week's
PLoS Medicine that in some US states the modification of lethal injection protocols is tantamount to experimentation upon prisoners without the prisoners' consent and without any ethical safeguards.
Study finds parents use cough medicines on under-2s despite the warnings
More than 40 per cent of parents have used cough medicine for children younger than two – even though it is not recommended, nor proven effective for children in this age group, an Australia-first study has found.
Risks for painkiller abuse do not outweigh benefits in chronic pain
As controversy swirls about proper clinical use of opioids and other potent pain medications, research reported at the American Pain Society annual meeting shows that, contrary to widespread beliefs, less than 3 percent of patients with no history of drug abuse who are prescribed opioids for chronic pain will show signs of possible drug abuse or dependence.